Hypertrophic scars remain one of the most persistent challenges in wound healing, often resulting in excessive fibrosis, disfigurement, and long-term functional impairment. Researchers now report a ...
An international team led by National University of Singapore researchers has linked secondary lymphedema to excessive ...
CollPlant is now moving towards clinical trials and scaling and optimizing its manufacturing to ensure readiness for the upcoming clinical trials REHOVOT, Israel, Sept. 30, 2025 /PRNewswire/ -- ...
Please provide your email address to receive an email when new articles are posted on . Two calcium hydroxyapatite-based derma fillers were compared. Filler suspended in carboxymethylcellulose induced ...
CollPlant Biotechnologies’ photocurable dermal filler technology receives Korean Patent: Rehovot, Israel Saturday, February 28, 2026, 14:00 Hrs [IST] CollPlant Biotechnologies, ...
CollPlant Biotechnologies (Nasdaq: CLGN), a regenerative and aesthetic medicine company developing innovative technologies ...
Michael Freeman is the founder of The Skin Centre, a private dermatology practice which also offers dermal fillers. Fillers are now one of the most common non-surgical cosmetic procedures. Adding ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results